News | January 4, 2018

Deciphera Pharmaceuticals Initiates Phase 3 Clinical Study with DCC-2618 in Patients with Advanced Gastrointestinal Stromal Tumors (“INVICTUS” study) – Pivotal Study to Evaluate the pan-KIT and PDGFRα inhibitor, DCC-2618, in Heavily Pretreated Patients with...